IPPRA / Grant Monitor

2026-07-07
← Board

DoW Melanoma Research Program Survivorship Research Award

HT942526MRPSRA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health mental behavioral health Science & Technology R&D

Closes
2026-10-14 · 99 d
Award ceiling
Award floor
Program funding
$2,040,000
Expected awards
2
Cost sharing
No
Posted
2026-05-21
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

This award funds innovative melanoma survivorship research to improve the near-term health and well-being of melanoma survivors, their families, and/or care partners, and requires at least one melanoma consumer collaborator or melanoma-supporting organization.

Funds
applied research
University
direct
social behavioral
substantial
engineering
minor
life biomedical
central
computational data
minor

⚑ Clinical trials are allowed. · Application must include at least one melanoma consumer collaborator (survivor, family member, and/or care partner) or a melanoma-community supporting organization. · Projects focused exclusively on animal models are not responsive. · Projects considering survival only, without quality of life, overall health, and/or function, are not responsive.

Unit fits — one characterization, each unit's own rules

IPPRA 58 good peripheral portfolio topic: public_health; signature methods: community engaged, surveys longitudinal; social/behavioral work is substantial; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds applied research
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity.

Distinctive Features:

· The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research.

· Clinical trials are allowed.

Apply

View on Grants.gov → CONTACT: Jamie Shortall Grant Officer <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING